Cargando…

Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial

BACKGROUND: Employers can purchase high quality depression products that provide the type, intensity and duration of depression care management shown to improve work outcomes sufficiently for many employers to achieve a return on investment. The purpose of this randomized controlled trial was to tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Rost, Kathryn M, Marshall, Donna, Xu, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263121/
https://www.ncbi.nlm.nih.gov/pubmed/25248854
http://dx.doi.org/10.1186/1472-6963-14-426
_version_ 1782348515119202304
author Rost, Kathryn M
Marshall, Donna
Xu, Stanley
author_facet Rost, Kathryn M
Marshall, Donna
Xu, Stanley
author_sort Rost, Kathryn M
collection PubMed
description BACKGROUND: Employers can purchase high quality depression products that provide the type, intensity and duration of depression care management shown to improve work outcomes sufficiently for many employers to achieve a return on investment. The purpose of this randomized controlled trial was to test an intervention to encourage employers to purchase a high quality depression product for their workforce. METHODS: Twenty nine organizations recruited senior health benefit professional members representing public or private employers who had not yet purchased a depression product for all 100+ workers in their company. The research team used randomization blocked by company size to assign eligible employers to: (1) a presentation encouraging employers to purchase a high quality depression product accompanied by a scientifically-derived return on investment estimate, or (2) a presentation encouraging employers to work with their most subscribed health plan to improve depression treatment quality indicators. Two hundred ninety three employers (82.3% of 356) completed baseline data immediately before learning that 140 employers had been randomized to the evidence-based (EB) depression product presentation and 153 had been randomized to the usual care (UC) depression treatment quality indicator presentation. Analysis of 250 (85.3% of 293) employers who completed web-based interviews at 12 and/or 24 months was conducted to determine presentation impact on depression product appraisal and purchasing behavior. RESULTS: The intervention had no impact on depression product appraisal in 232 subjects (F = 2.36, p = .07) or depression product purchasing (chisquare = 1.82, p = .44) in 250 subjects. Depression product appraisal increased in companies with greater health benefit generosity whose benefit professionals were male. Depression product purchasing behavior increased in small companies compared to large companies, companies who knew a vendor that sold depression products at baseline, companies with greater health benefit risk taking, and companies with less politicalization of health care benefit decision making. CONCLUSIONS: Policy makers need to build innovative bridges to the employer community to convince them to purchase evidence-based benefits, even when benefits offer potential financial savings. TRIAL REGISTRATION: Clinical Trials Registration Number: NCT01013220.
format Online
Article
Text
id pubmed-4263121
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42631212014-12-12 Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial Rost, Kathryn M Marshall, Donna Xu, Stanley BMC Health Serv Res Research Article BACKGROUND: Employers can purchase high quality depression products that provide the type, intensity and duration of depression care management shown to improve work outcomes sufficiently for many employers to achieve a return on investment. The purpose of this randomized controlled trial was to test an intervention to encourage employers to purchase a high quality depression product for their workforce. METHODS: Twenty nine organizations recruited senior health benefit professional members representing public or private employers who had not yet purchased a depression product for all 100+ workers in their company. The research team used randomization blocked by company size to assign eligible employers to: (1) a presentation encouraging employers to purchase a high quality depression product accompanied by a scientifically-derived return on investment estimate, or (2) a presentation encouraging employers to work with their most subscribed health plan to improve depression treatment quality indicators. Two hundred ninety three employers (82.3% of 356) completed baseline data immediately before learning that 140 employers had been randomized to the evidence-based (EB) depression product presentation and 153 had been randomized to the usual care (UC) depression treatment quality indicator presentation. Analysis of 250 (85.3% of 293) employers who completed web-based interviews at 12 and/or 24 months was conducted to determine presentation impact on depression product appraisal and purchasing behavior. RESULTS: The intervention had no impact on depression product appraisal in 232 subjects (F = 2.36, p = .07) or depression product purchasing (chisquare = 1.82, p = .44) in 250 subjects. Depression product appraisal increased in companies with greater health benefit generosity whose benefit professionals were male. Depression product purchasing behavior increased in small companies compared to large companies, companies who knew a vendor that sold depression products at baseline, companies with greater health benefit risk taking, and companies with less politicalization of health care benefit decision making. CONCLUSIONS: Policy makers need to build innovative bridges to the employer community to convince them to purchase evidence-based benefits, even when benefits offer potential financial savings. TRIAL REGISTRATION: Clinical Trials Registration Number: NCT01013220. BioMed Central 2014-09-24 /pmc/articles/PMC4263121/ /pubmed/25248854 http://dx.doi.org/10.1186/1472-6963-14-426 Text en © Rost et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rost, Kathryn M
Marshall, Donna
Xu, Stanley
Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial
title Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial
title_full Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial
title_fullStr Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial
title_full_unstemmed Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial
title_short Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial
title_sort intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263121/
https://www.ncbi.nlm.nih.gov/pubmed/25248854
http://dx.doi.org/10.1186/1472-6963-14-426
work_keys_str_mv AT rostkathrynm interventionimpactondepressionproductappraisalandpurchasingbehaviorbyemployersarandomizedtrial
AT marshalldonna interventionimpactondepressionproductappraisalandpurchasingbehaviorbyemployersarandomizedtrial
AT xustanley interventionimpactondepressionproductappraisalandpurchasingbehaviorbyemployersarandomizedtrial